Connable Office Inc’s Emergent Biosolutions EBS Stock Holding History

Connable Office Inc’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,409	Closed	-$263K	–	211
2022 Q1	$263K	Buy	+6,409	New	+$283K	0.04%	187
2021 Q4	–	Sell	-6,122	Closed	-$307K	–	224
2021 Q3	$307K	Buy	6,122 +1,739	+40%	+$105K	0.04%	173
2021 Q2	$276K	Hold	4,383	–	–	0.04%	180
2021 Q1	$407K	Sell	4,383 -267	-6%	-$27.3K	0.06%	154
2020 Q4	$417K	Sell	4,650 -287	-6%	-$26.3K	0.06%	144
2020 Q3	$510K	Sell	4,937 -4,851	-50%	-$523K	0.1%	113
2020 Q2	$774K	Buy	9,788 +1,009	+11%	+$75.2K	0.15%	88
2020 Q1	$508K	Buy	8,779 +3,252	+59%	+$187K	0.12%	89
2019 Q4	$298K	Hold	5,527	–	–	0.05%	143
2019 Q3	$289K	Buy	5,527 +109	+2%	+$5.08K	0.05%	139
2019 Q2	$262K	Buy	+5,418	New	+$260K	0.05%	147

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connable Office Inc's EBS Position: Q2 2022 in Review

Connable Office Inc sold out of Emergent Biosolutions (EBS) in Q2 2022, closing a stake of 6,409 shares — an estimated $263K sold.

Connable Office Inc first reported a position in EBS in Q2 2019 and held it in 11 quarters. The position peaked at $774K in Q2 2020. 232 funds tracked by Wall St. Rank hold EBS as of Q2 2022.

Connable Office Inc reported no remaining Emergent Biosolutions position as of Q2 2022 after selling out during the quarter.
Connable Office Inc sold 6,409 Emergent Biosolutions shares in Q2 2022, an estimated $263K.
Connable Office Inc first reported a position in Emergent Biosolutions in Q2 2019 and held it in 11 quarters.
Connable Office Inc's Emergent Biosolutions position peaked at $774K in Q2 2020.
232 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.

Based on Connable Office Inc's 13F filing for Q2 2022, filed 1 Aug 2022.